Zentalis Pharmaceuticals (ZNTL) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Zentalis Pharmaceuticals (ZNTL).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | 27M | - | - | 41M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 29M (-2.61%) | 29M (+28.50%) | 23M (-16.88%) | 28M (+1.32%) | 27M (-17.35%) | 33M (-10.46%) | 37M (-23.91%) | 48M (-2.42%) | 50M (-3.82%) | 52M (+10.24%) | 47M (+9.58%) | 43M (-12.14%) | 49M (+19.60%) | 41M (-3.70%) | 42M (-3.76%) | 44M (-4.94%) | 46M (+19.95%) | 38M (-28.81%) | 54M (+20.62%) | 45M (+16.62%) | 38M (+30.05%) | 30M (+19.66%) | 25M (+41.38%) | 17M (+31.60%) | 13M (+11.71%) | 12M (+10.52%) | 11M (+23.59%) | 8.69M (+22.57%) | 7.09M |
Selling General And Administrative | 9.14M (+15.55%) | 7.91M (-26.62%) | 11M (+27.57%) | 8.45M (-20.13%) | 11M (-73.56%) | 40M (+173.85%) | 15M (-12.83%) | 17M (+6.48%) | 16M (-3.79%) | 16M (+2.57%) | 16M (+1.85%) | 16M (-4.34%) | 16M (+46.95%) | 11M (-7.24%) | 12M (-38.85%) | 20M (+66.86%) | 12M (+20.72%) | 9.75M (+9.92%) | 8.87M (-14.38%) | 10M (-13.31%) | 12M (+11.47%) | 11M (+6.14%) | 10M (+1.81%) | 9.92M (+215.92%) | 3.14M (+3.29%) | 3.04M (+65.22%) | 1.84M (-5.64%) | 1.95M (+19.63%) | 1.63M |
Operating Expenses | 38M (+1.23%) | 37M (+10.85%) | 34M (-6.46%) | 36M (-20.96%) | 46M (-40.53%) | 77M (+49.15%) | 51M (-21.06%) | 65M (-0.28%) | 65M (-3.81%) | 68M (+8.29%) | 63M (-39.65%) | 104M (+60.00%) | 65M (+25.51%) | 52M (-4.50%) | 54M (-14.61%) | 63M (+9.64%) | 58M (+20.11%) | 48M (-23.35%) | 63M (+14.04%) | 55M (+9.49%) | 50M (+25.12%) | 40M (+15.73%) | 35M (+26.99%) | 27M (+66.95%) | 16M (+9.99%) | 15M (+18.52%) | 13M (+18.23%) | 11M (+22.02%) | 8.72M |
Depreciation And Amortization | 150K (-6.25%) | 160K (0.00%) | 160K (0.00%) | 160K (-38.46%) | 260K (-18.75%) | 320K (0.00%) | 320K (-3.03%) | 330K (+3.13%) | 320K (-5.88%) | 340K (-2.86%) | 350K (+2.94%) | 340K (-5.56%) | 360K (0.00%) | 360K (-5.26%) | 380K (+8.57%) | 350K (+2.94%) | 340K (+61.90%) | 210K (+50.00%) | 140K (+16.67%) | 120K (+50.00%) | 80K (+166.67%) | 30K (-40.00%) | 50K (+25.00%) | 40K (0.00%) | 40K (0.00%) | 40K (+33.33%) | 30K (+50.00%) | 20K (0.00%) | 20K |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -37.85M (+1.23%) | -37.39M (+10.85%) | -33.73M (-6.46%) | -36.06M (-20.96%) | -45.62M (-8.49%) | -49.85M (-3.07%) | -51.43M (-21.06%) | -65.15M (+163.13%) | -24.76M (-63.55%) | -67.92M (+8.29%) | -62.72M (-39.65%) | -103.92M (+60.00%) | -64.95M (+25.51%) | -51.75M (-4.50%) | -54.19M (-14.61%) | -63.46M (+9.64%) | -57.88M (+20.11%) | -48.19M (-23.35%) | -62.87M (+14.04%) | -55.13M (+9.49%) | -50.35M (+25.12%) | -40.24M (+15.73%) | -34.77M (+26.99%) | -27.38M (+66.95%) | -16.40M (+10.07%) | -14.90M (+18.44%) | -12.58M (+18.34%) | -10.63M (+21.90%) | -8.72M |
Ebit | -37.85M (+1.23%) | -37.39M (+10.85%) | -33.73M (-6.46%) | -36.06M (-20.96%) | -45.62M (-8.49%) | -49.85M (-3.07%) | -51.43M (-21.06%) | -65.15M (+163.13%) | -24.76M (-63.55%) | -67.92M (+8.29%) | -62.72M (-39.65%) | -103.92M (+60.00%) | -64.95M (+25.51%) | -51.75M (-4.50%) | -54.19M (-14.61%) | -63.46M (+9.64%) | -57.88M (+20.11%) | -48.19M (-23.35%) | -62.87M (+14.04%) | -55.13M (+9.49%) | -50.35M (+25.12%) | -40.24M (+15.73%) | -34.77M (+26.99%) | -27.38M (+66.95%) | -16.40M (+10.07%) | -14.90M (+18.44%) | -12.58M (+18.34%) | -10.63M (+21.90%) | -8.72M |
EBITDA | -37.70M (+1.24%) | -37.24M (+10.93%) | -33.57M (-6.49%) | -35.90M (-20.86%) | -45.36M (-8.42%) | -49.53M (-3.09%) | -51.11M (-21.15%) | -64.82M (+165.22%) | -24.44M (-63.84%) | -67.58M (+8.35%) | -62.37M (-39.78%) | -103.57M (+60.35%) | -64.59M (+25.69%) | -51.39M (-4.52%) | -53.82M (-14.72%) | -63.11M (+9.70%) | -57.53M (+19.90%) | -47.98M (-23.51%) | -62.73M (+14.03%) | -55.01M (+9.43%) | -50.27M (+25.02%) | -40.21M (+15.81%) | -34.72M (+26.99%) | -27.34M (+67.11%) | -16.36M (+10.09%) | -14.86M (+18.31%) | -12.56M (+18.38%) | -10.61M (+21.95%) | -8.70M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -360.00K | 100K (-16.67%) | 120K (-14.29%) | 140K | -370.00K | 120K (+50.00%) | 80K (-50.00%) | 160K | -130.00K | 10K (-80.00%) | 50K (-28.57%) | 70K |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -360.00K | 100K (-16.67%) | 120K (-14.29%) | 140K | -370.00K | 120K (+50.00%) | 80K (-50.00%) | 160K | -130.00K | 10K (-80.00%) | 50K (-28.57%) | 70K |
Net Income | |||||||||||||||||||||||||||||
Income Before Tax | -35.23M (+1.32%) | -34.77M (+30.27%) | -26.69M (-0.67%) | -26.87M (-44.35%) | -48.28M (+1.26%) | -47.68M (+18.67%) | -40.18M (-54.35%) | -88.01M | 10M | -292.91M | - | - | - | -64.80M (+23.92%) | -52.29M (-17.05%) | -63.04M (+9.73%) | -57.45M (+15.04%) | -49.94M (+346.29%) | -11.19M (-79.66%) | -55.02M (+9.49%) | -50.25M (+25.85%) | -39.93M (+15.24%) | -34.65M (+26.97%) | -27.29M (+68.15%) | -16.23M (+11.55%) | -14.55M (+15.75%) | -12.57M (+18.70%) | -10.59M (+22.29%) | -8.66M |
Income Tax Expense | 120K (-72.73%) | 440K | - | - | - | -200.00K (+566.67%) | -30.00K | 270K (+92.86%) | 140K | -130.00K | 30K | -600.00K | 110K | -360.00K (+125.00%) | -160.00K | 20K (-33.33%) | 30K (-81.25%) | 160K | -700.00K | 50K (-75.00%) | 200K (-53.49%) | 430K (+2050.00%) | 20K | - | - | - | - | 10K | - |
Net Income From Continuing Operations | -35.35M (+0.37%) | -35.22M (+31.96%) | -26.69M (-0.67%) | -26.87M (-44.35%) | -48.28M (+1.71%) | -47.47M (+18.20%) | -40.16M (-54.51%) | -88.28M | 10M | -60.92M (+9.71%) | -55.53M (-50.65%) | -112.53M (+78.00%) | -63.22M (+15.01%) | -54.97M (+1.05%) | -54.40M (-20.42%) | -68.36M (+15.71%) | -59.08M (+18.02%) | -50.06M (+1094.75%) | -4.19M (-92.32%) | -54.57M (+9.36%) | -49.90M (+23.82%) | -40.30M (+16.64%) | -34.55M (+28.63%) | -26.86M (+66.52%) | -16.13M (+11.16%) | -14.51M (+17.59%) | -12.34M (+17.86%) | -10.47M (+25.54%) | -8.34M |
Net Income | -35.35M (+0.37%) | -35.22M (+31.96%) | -26.69M (-0.67%) | -26.87M (-44.35%) | -48.28M (+1.71%) | -47.47M (+18.20%) | -40.16M (-54.51%) | -88.28M | 10M | -60.92M (+9.71%) | -55.53M (-50.65%) | -112.53M (+78.00%) | -63.22M (+15.01%) | -54.97M (+1.05%) | -54.40M (-20.42%) | -68.36M (+15.71%) | -59.08M (+18.02%) | -50.06M (+1094.75%) | -4.19M (-92.32%) | -54.57M (+9.36%) | -49.90M (+23.82%) | -40.30M (+16.64%) | -34.55M (+28.63%) | -26.86M (+66.52%) | -16.13M (+11.16%) | -14.51M (+17.59%) | -12.34M (+17.86%) | -10.47M (+25.54%) | -8.34M |
Comprehensive Income Net Of Tax | -35.60M (-74.09%) | -137.42M (+417.39%) | -26.56M (-2.25%) | -27.17M (-43.96%) | -48.48M (-71.05%) | -167.47M (+332.74%) | -38.70M (-56.47%) | -88.91M | 8.65M | -288.64M (+419.60%) | -55.55M (-50.54%) | -112.31M (+79.93%) | -62.42M (-73.78%) | -238.03M (+333.65%) | -54.89M (-20.48%) | -69.03M (+14.94%) | -60.06M (-62.20%) | -158.89M (+3638.59%) | -4.25M (-92.21%) | -54.53M (+9.30%) | -49.89M (-57.65%) | -117.80M (+241.05%) | -34.54M (+28.64%) | -26.85M (+66.46%) | -16.13M (-64.67%) | -45.66M (+270.02%) | -12.34M (+16.42%) | -10.60M | - |